Alerus Investment Advisors’s Pfizer PFE Stock Holding History

Alerus Investment Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$5.81M	Buy	206,636 +24,519	+13%	+$700K	1.01%	30
2015 Q4	$5.58M	Buy	182,117 +17,160	+10%	+$540K	0.93%	29
2015 Q3	$4.92M	Sell	164,957 -2,380	-1%	-$76.3K	0.87%	28
2015 Q2	$5.52M	Buy	167,337 +86	+0.1%	+$2.8K	0.92%	27
2015 Q1	$5.51M	Sell	167,251 -2,675	-2%	-$85K	0.92%	28
2014 Q4	$5.02M	Sell	169,926 -1,480	-0.9%	-$42.4K	0.85%	31
2014 Q3	$4.81M	Buy	171,406 +13,957	+9%	+$392K	0.83%	31
2014 Q2	$4.43M	Buy	157,449 +1,626	+1%	+$46.4K	0.76%	32
2014 Q1	$4.75M	Sell	155,823 -31,608	-17%	-$942K	1.02%	29
2013 Q4	$5.45M	Sell	187,431 -41,138	-18%	-$1.2M	1.2%	25
2013 Q3	$6.23M	Buy	228,569 +24,178	+12%	+$658K	1.24%	28
2013 Q2	$5.43M	Buy	+204,391	New	+$5.65M	0.84%	47

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Alerus Investment Advisors's PFE Position: Q1 2016 in Review

Alerus Investment Advisors increased its Pfizer (PFE) stake by 13% in Q1 2016, buying an estimated $700K and bringing the position to 206,636 shares worth $5.81M. The position accounts for 1.01% of the portfolio, ranked #30.

Alerus Investment Advisors first reported a position in PFE in Q2 2013 and has held it in 12 quarters since. The position peaked at $6.23M in Q3 2013. 1,968 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

Alerus Investment Advisors held 206,636 shares of Pfizer worth $5.81M as of Q1 2016.
Alerus Investment Advisors bought 24,519 Pfizer shares in Q1 2016, an estimated $700K.
Pfizer made up 1.01% of Alerus Investment Advisors's portfolio in Q1 2016, its #30 holding.
Alerus Investment Advisors first reported a position in Pfizer in Q2 2013 and has held it in 12 quarters since.
Alerus Investment Advisors's Pfizer position peaked at $6.23M in Q3 2013.
1,968 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on Alerus Investment Advisors's 13F filing for Q1 2016, filed 4 May 2016.